chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 23Mar2021 (Batch/Lot number: unknown) at the age of 62 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Vitamin B12 deficiency" (unspecified if ongoing); "Parkinson's disease" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE ~Lot no: unknown), for COVID-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset 24Mar2021, outcome "not recovered", described as "Fatigue". Therapeutic measures were not taken as a result of fatigue. Additional information: The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not tested for COVID-19 since having the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2 wk p/vax pt devel erythematous maculopapular rash on palms,plantar surfaces & legs. Also devel low-grade fever & diffuse joint pain.
Tested positive for COVID; A spontaneous report was received from a pharmacist concerning a patient was participating in the mRNA-1273 Emergency Use the patient was positive for tested positive for COVID.   The patient's medical history was not provided. No relevant concomitant medications were reported.   The patient received their first of two planned doses of mRNA-127 intramuscularly in the for prophylaxis of COVID-19 infection. The pharmacist then reported the patient and was not positive for COVID but guess the next day the result came back from the last time they did their test as positive.  No treatment information was provided.   The seriousness criteria for event was non-serious.  Action taken with mRNA-1273 in response to the event(s) was not reported.  The event, was not positive for COVID but guess the next day the result came back from the last time they did their test as positive, was considered unknown.~; Reporter's Comments: Based on the current available information, the mRNA-1723 does not contain a virus capable of causing infection and with the occurrence of Covid-19 infection after vaccination, this event is assessed as unlikely related to mRNA-1273.
I experienced mild and transient chest pain a few days after receiving my 2nd and 3rd shots, lasting for about a week. About 4 weeks after getting the 3rd shot, at about 9AM of 12/18/2021, I started experiencing persistent and mild to moderate chest pain while at work (retail pharmacist) that lasted throughout the day. By the end of the shift at 5pm, the chest pain was across my entire upper chest area. I self-treated with ibuprofen and rest after I got home from work, which improved my condition. After waking up the next morning at about 7am, the chest pain returned and was persistent. I went to urgent care around 9:30am where an EKG, chest x-ray, and labs were taken. All readings came back normal but the chest pain continued. I was instructed to take ibuprofen to decrease the pain.  Now one month after urgent care, I still experience transient chest pains, sometimes multiple times a day, or only a few days per week.
Covid-19 Bivalent booster given instead of Moderna Covid-19 Vaccine for second dose in primary series.
In 1990 pt had 2 doses of Anthrax vaccine in L deltoid. She has had recurrent episodes of panniculitis at the site of injection since that time
Started with HA & chills about 10PM after being out in weather.  Had gotten home about 6PM did homework.  Weak decreased HA at school next day no N/V neck stiff but not on exam.  Arm sore.  Mom p/u from school 10AM slept until came in to be seen 3PM.
10 mins after vaccine given patient complained of "thick throat" difficulty swallowing. No other symptoms noted
Chief Complaint: Covid-19 (COVID + on Monday) complaining of general malaise, nausea and vomiting.  No signs of any pulmonary infiltrates on chest x-ray. Currently on room air. Monitor for now.   positive for COVID-19.  Patient was noted to be in acute renal failure.
Can't properly move her feet within the past hour after receiving the first dose; Numbness in toes and bottoms of feet; This is a spontaneous report from a contactable consumer or other non hcp.     A 45-year-old female (non-pregnant) patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration, administered on 24Feb2021 08:45  (at the age of 45-years-old)  as SINGLE DOSE for covid-19 immunisation.  Medical history included type 2 diabetes mellitus from an unknown date and unknown if ongoing, hypertension from an unknown date and unknown if ongoing, OCD (obsessive-compulsive disorder) from an unknown date and unknown if ongoing, anxiety from an unknown date and unknown if ongoing, Allergy to drug from an unknown date and unknown if ongoing (Most pain medications). The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination was yes. Prior to vaccination, the patient did not diagnosed with COVID-19. Since the vaccination, the patient did not tested for COVID-19. The patient stated received first dose of vaccine today at 8:45am. Caller said her toes become numb on 24Feb2021 15:45 and can't properly move her feet within the past hour after receiving the first dose on an unspecified date. Therapeutic measure were taken as no for events. The outcome of event numbness in toes and bottoms of feet was not recovered and outcome of event can't properly move her feet within the past hour after receiving the first dose was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Dizziness/light headed (almost passed out) Vomiting Diarrhea Exhaustion (slept for 5 hrs) High blood sugar (300)
pt recv vax 18JUN97 & 22JUN97 pt exp erythema mult;past med hx reported show that pt exp erythema mult p/vax w/HIBTITER, infanix & IPV-IPOL on 17APR(7;
Got PNEUMOVAX and FLUVIRIN on same arm. Developed swelling and redness in left arm about 5-7 inches.
patient took the first and second dose of the Shingrix vaccine within a 5 week interval; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: patient took the first and second dose of the Shingrix vaccine within a 5 week interval). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 7-JUL-2023 Pharmacist reported a patient took the first and second dose of the Shingrix vaccine within a 5 week interval. Patient received vaccine at a different facility.  Reporter did not administer vaccine to patient so did not have too many details.
Patient came in for a booster shot of covid vaccine.  He was given Moderna by mistake as he is not 18 years of age yet.  He was previously given the Pfizer, but mistakenly got moderna this time.  No adverse reaction and provider and parents were notified
Started feeling ill, starting vomiting for 27 straight hours, wheezing, was unable to keep food or water down.  Unable to sit up .
Vaginal lesions/ulcers within two days of receiving both the first dose and the second dose of the vaccine.; Vaginal lesions/ulcers within two days of receiving both the first dose and the second dose of the vaccine.; This is a spontaneous report from a contactable consumer. A 13-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0185) via an unspecified route of administration in the arm left on 14May2021(at the age of 13-year-old) and second dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0217) via an unspecified route of administration in the arm left on 04Jun2021(at the age of 13-year-old) as a dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021,  the patient experienced vaginal lesions/ulcers within two days of receiving both the first dose and the second dose of the vaccine. It was reported that the patient previously had COVID-19 four weeks before her first vaccine dose. The patient was 13 years and is not sexually active. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events.  On an unknown date, the patient underwent HSV(Herpes simplex virus), HPV(Human papillomavirus), GBS(Group B streptococcus) and various STDs(Sexually transmitted diseases) test and all tested negative. The clinical outcome of the event vaginal lesions and vaginal ulcers was not recovered at the time of this report.
Tinnitus in right ear only with mild loss of hearing that began on 4/9 and continues to 4/12.
When got out of bed, muscles of legs, arms, and buttocks were painful when moving, continued for 1 1/2 weeks.  Left Arm was painful on using.
1/19 10am - headache, extreme fatigue, body aches, nausea, vomited once, arm muscle is very sore Evening - chills and mild fever (100.5)  1/20 6am - still fatigued and nauseous with reduced fever (100.2) 12pm - started feeling better, no more fever (99.7)
Rash lt deltoid lt lateral trunk lt sole of foot. child now has purpura w/petechiae.
My hands and feet are on and off tingly and it?s not going away. No treatment sought yet.
At the time of the injection the patient reports nothing unusual. The following day 1/20 there was increased pain which is still present 1/22. Pain is limiting ability to lift arm and to sleep. NSAIDs are partially helpful. There was 1 brief episode of numbness: tingling of hand. I advised continued NSAID: F/U by phone in 2d.
Soreness and swelling at injection site, shivering No medical treatment sought Except for sore arm, side effects were gone next day
FACIAL NUMBNESS (Bells Palsy), EAR PAIN, NECK PAIN, SHOULDER PAIN Narrative:
04/23/2022 Vaccination.  05/28/2022 I just started getting more of the PVC's; benign irregular heartbeat. I have a history but never prevalent. This was about 5 weeks after the vacation and it was a lot. 07/25/2022 I am still having them more then I have had in a long time. I am seeing a cardiologist regarding this but no medication as this time.
25 hours after getting the 2nd vaccine. I had a fever of 101.9 then I took 4 ibuprofen 200mg and ten minutes later my temperature dropped to 97.3
Received 1st dose of vaccine within less than the recommended 90 days following being given convalescent plasma.  Came in on 4/7/21 for 2nd dose and incident was noted at that time.  Denied any problem after receiving 1st dose.
Therapy non-responder. Report A0370075A describes a 48 y.o. male who did not respond to the Hep B vaccine recombinant (Engerix-B) immunization series. The medical history, concurrent conditions, and concurrent medications were not specified. On 9/11/01, 10/11/01, and 3/11/02, the vaccinee received his first (lot ENG5168A2; expiry 5/14/02), second (lot ENG5168A2; expiry, 5/14/02), and third (lot ENG5272A2; expiry, 8/20/03) injections of Engerix-B, respectively. A titer (NOS) drawn for this vaccinee on 5/16/02, 66 days after the 3rd injection of Engerix-B, was "negative"; measurable titers were not obtained." The reporter stated that the event was probably related to Engerix-B.
No adverse events were reported; Products were administered post TE; This spontaneous report was received from a registered nurse referring to a 33-year-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.     On 24-MAR-2023, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) injection (lot # W001518, expiration date: 13-JAN-2024 or lot # W007040, expiration date: 29-FEB-2024; no exact lot# and expiration date was provided) for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  This case was received from the same reporter with another 17 cases: 2305USA007704, 2305USA009079,2305USA009080,2305USA009081,2305USA009082, 2305USA009084, 2305USA009085, 2305USA009086, 2305USA009087, 2305USA009088, 2305USA009089, 2305USA009090, 2305USA009091, 2305USA009092, 2305USA009093, 2305USA009094, 2305USA009095.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in right arm / t lifted up the arm and still sore for a week) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in right arm / t lifted up the arm and still sore for a week). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Pain in right arm / t lifted up the arm and still sore for a week) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.
pt stated that about a week after her vax she noticed itching around the injection site.  she thinks she may have irritated it by wearing a sweater.
systemic inflammatory; asymptomatic COVID-19 infection; asymptomatic COVID-19 infection; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient developed a devastating systemic inflammatory response within 36 hours of receiving his second Pfizer vaccine shot. Patient's deadly inflammatory state followed his vaccination. Administration of the Pfizer vaccine ignited a deadly inflammatory response in patient's body acutely, in a setting where he had a recent asymptomatic COVID-19 infection. The patient died on an unspecified date. It was not reported if an autopsy was performed. Outcome of all events were fatal.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: asymptomatic COVID-19 infection; asymptomatic COVID-19 infection; systemic inflammatory
4 shots.  Two in each arm.  He slumped over, was pale, pupils big as saucers, legs stiffened and arm flexed with a little shake.  It lasted about 20-30 seconds.  When he came to he was so confused.  He then continued getting pale and woozy for about 30 minutes.
Tested positive for COVID after being vaccinated . Very sick , headache , Sob , body aches fever .
Given TD 12FEB91 p/being cut on finger while cleaning a meat slicer; Returned 13FEB91 & arm was sl. reddened; Instructed to use Tylenol & cold packs for discomfort; 14FEB91 lt upper arm was edematous & reddened w/blisters; Benadryl & Medrol
Actually, this is a positive reaction for the Pfizer vaccine. I had a consistent cough for two months or more and had to sit up in bed almost every night in order to sleep. The night after I received the vaccine, I was able to sleep all night without coughing and the cough went away entirely. The cough went away and never returned.  Another experience happened after a party with some young people. Woke up sneezing continuously for dozens of sneezing events. I then felt a tingling sensation in my legs. Sneezing went away and did not have any other symptoms after this event.
Body aches; Felt feverish; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the left arm on 24Mar2021 at 13:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient was allergic to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), estradiol (MANUFACTURER UNKNOWN), progesterone (MANUFACTURER UNKNOWN) and paroxetine hydrochloride (PAXIL), all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 03Mar2021 at 13:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Mar2021 at 02:00, the patient felt feverish. The patient had chills, body aches and fatigue approximately 12-13 hours after second dose. Symptoms persisted for 48 hours. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events felt feverish, chills, body aches and fatigue. The clinical outcomes of the events felt feverish, chills, body aches and fatigue were recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Client felt fine for 2 weeks post vaccination. Exactly 14 days later she developed acute onset of lethargy, Weakness, headache, and body aches.  All known side effects but they didn't appear until 14 days later.
sore arm that started day after injection but continued for a month. patient says has not gotten worse but remains the same or healing slowly
The biggest effects from Dose 1 are the fatigue, migraines and shingles. I don't have a rash but I still can feel it all over my face and palm of my hands. I have been treated prescribed medication for shingles it hasn't helped.
A week after receiving the flu shot, the patient started experiencing pain in the right arm and a decreased mobility and range of motion in the right arm as well. She said she became really ill with flu-like symptoms and had to go to the hospital. Her neurological symptoms has gotten worse since it appeared.
itching 2 hours after vaccine (chest, nose, scalp, shoulder blades) redness on chest and face, burning sensation on face, hives on hands
Pt reported "I don't remember getting a third vaccine."  Vaccine not listed on system. HPV given.  Reviewed immunization record with pt. Pt stated " I remember getting the 1st two, one month apart. I don't remember getting a 3rd."
COVID symptoms with moderately severe sore throat and ear ache and fatigue beginning July 23, 2022.  Positive COVID test July 26, 2022.  Symptoms progressed to include frequent to continuous cough with other symptoms plus intermittent elevated temperature with highest 100.3F on July 27, 2022.
Migraine; Feeling foggy; Malaise; Swollen lymph nodes; Could not lift arm more than a few inches
erythrodermic psoriasis; Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination;  This is a literature report for the following literature source(s): A 58-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Single), for covid-19 immunisation. The following information was reported: ERYTHRODERMIC PSORIASIS (medically significant), 1 week after the suspect product(s) administration, outcome "recovering"; PSORIASIS (medically significant), 1 week after the suspect product(s) administration, outcome "recovering", described as "Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination". The patient underwent the following laboratory tests and procedures: Body surface area: greater than 80; Hepatitis C virus test: Positive. Therapeutic measures were taken as a result of erythrodermic psoriasis, psoriasis. Sender's Comments: Based on the available information in the case, the causal association between the events erythrodermic psoriasis, psoriasis and the suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
A nurse reported that a female "over 60" tested positive for hepatitis B surface antigen after being vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. The pt's medical history included renal failure (cause not reported) treated with hemodialysis. Concurrent medications were not reported. On 03/03/2003, the pt received a 40-mcg injection of Engerix-B. Two days later, on 03/05/2003, testing for hepatitis B surface antigen was "positive"; this test had "previously" been "negative". A healthcare professional was consulted regarding the positive test. The reporting nurse considered the event to be possibly related to Engerix-B administration.
the muscles in his arm become essentially worthless that it affects his lifting capacity; the muscles in his arm become essentially worthless that it affects his lifting capacity; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown) intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULAR WEAKNESS (non-serious), VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious), outcome "unknown" and all described as "the muscles in his arm become essentially worthless that it affects his lifting capacity".  Additional information: The caller mentioned that he called before asking for information about the Pfizer COVID vaccine but wasn't able to get the answer he is looking for. He said he got the COVD vaccine the muscles in his arm become essentially worthless that it affects his lifting capacity and he is asking on how will Pfizer fix this flaw on the vaccine. He added that he's never getting it again because every time he gets the vaccine he needs to plan in advance.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recvd vax 28JUL95 & 21AUG95 pt was covered w/chicken pox & was seen by MD;No further details were provided;